: [EMAIL PROTECTED] on behalf of Ted Harding
Sent: Sat 6/16/2007 9:33 AM
To: r-help@stat.math.ethz.ch
Subject: Re: [R] R vs. Splus in Pharma/Devices Industry
On 15-Jun-07 19:30:45, Douglas Bates wrote:
On 6/15/07, Nicholas Lewin-Koh [EMAIL PROTECTED] wrote:
Hi,
Probably when the statistical
On 16-Jun-07 01:12:18, Marc Schwartz wrote:
On Sat, 2007-06-16 at 00:43 +0100, [EMAIL PROTECTED] wrote:
On 15-Jun-07 19:43:55, John Kane wrote:
--- Douglas Bates [EMAIL PROTECTED] wrote:
On 6/15/07, Nicholas Lewin-Koh [EMAIL PROTECTED]
wrote:
[...]
I think you mean A, not Z. First
-Original Message-
From: Kuhn, Max [mailto:[EMAIL PROTECTED]
Sent: Thursday, June 14, 2007 3:11 PM
To: Greg Snow; [EMAIL PROTECTED]; r-help@stat.math.ethz.ch
Subject: RE: [R] R vs. Splus in Pharma/Devices Industry
Greg,
Thanks for the kind words about odfWeave
Greg,
I have looked at ooconvert, but unfortunately the current version is
limited to *nix, and I am currently in a MS windows world. I tried
getting it to run under cygwin at one point, but did not succeed at
the
time. Once it is available more generally, I will just set up
Makefiles
so
Hi,
I just saw this thread. This issue, and the larger scale issue of open
source in industry
is being addressed. One has to realize that the behemoth that is the
clinical aperatus
of the pharma industry is very conservative and very slow to change. In
many cases
switching to R would meean
Nicholas,
You're making me depressed!
Cody Hamilton, PhD
Edwards Lifesciences
Hi,
I just saw this thread. This issue, and the larger scale issue of open
source in industry
is being addressed. One has to realize that the behemoth that is the
clinical aperatus
of the pharma industry is very
On 6/15/07, Nicholas Lewin-Koh [EMAIL PROTECTED] wrote:
Hi,
I just saw this thread. This issue, and the larger scale issue of open
source in industry
is being addressed. One has to realize that the behemoth that is the
clinical aperatus
of the pharma industry is very conservative and very
--- Douglas Bates [EMAIL PROTECTED] wrote:
On 6/15/07, Nicholas Lewin-Koh [EMAIL PROTECTED]
wrote:
Hi,
I just saw this thread. This issue, and the larger
scale issue of open
source in industry
is being addressed. One has to realize that the
behemoth that is the
clinical aperatus
On 15-Jun-07 19:30:45, Douglas Bates wrote:
On 6/15/07, Nicholas Lewin-Koh [EMAIL PROTECTED] wrote:
Hi,
Probably when the statistical community is using Z big pharma will be
ready to use
R. %P
I think you mean A, not Z. First there was S, then there was R.
And, furthermore, A is
On 15-Jun-07 19:43:55, John Kane wrote:
--- Douglas Bates [EMAIL PROTECTED] wrote:
On 6/15/07, Nicholas Lewin-Koh [EMAIL PROTECTED]
wrote:
[...]
I think you mean A, not Z. First there was S, then
there was R.
We're regressing
But not to mediocrity! [1]
Ted.
[1] Practical
On Sat, 2007-06-16 at 00:43 +0100, [EMAIL PROTECTED] wrote:
On 15-Jun-07 19:43:55, John Kane wrote:
--- Douglas Bates [EMAIL PROTECTED] wrote:
On 6/15/07, Nicholas Lewin-Koh [EMAIL PROTECTED]
wrote:
[...]
I think you mean A, not Z. First there was S, then
there was R.
We're
4:07 PM
To: r-help@stat.math.ethz.ch
Subject: Re: [R] R vs. Splus in Pharma/Devices Industry
I should have also noted that Sweave is available for use
with R. This is offset, however, by the fact that I will
probably never be able to convince anyone to use Latex. This
is a pity as I
@stat.math.ethz.ch
Subject: Re: [R] R vs. Splus in Pharma/Devices Industry
I should have also noted that Sweave is available for use
with R. This is offset, however, by the fact that I will
probably never be able to convince anyone to use Latex. This
is a pity as I often find myself admiring reports
@stat.math.ethz.ch
Subject: Re: [R] R vs. Splus in Pharma/Devices Industry
Greg,
This is very interesting. Perhaps something similar could be
worked out here. Do you have to get MS Word users to work
only with the template you provide, or can they provide you
any old MS Word
Greg,
Thanks for the kind words about odfWeave.
These reports are usually put out as internal webpages for various
people in the organization to look at, so we could either go the
odfWeave approach and generate pdf files (not as automated as I would
like)
I agree that automating the
I should have also noted that Sweave is available for use with R. This is
offset, however, by the fact that I will probably never be able to convince
anyone to use Latex. This is a pity as I often find myself admiring
reports done in Latex as opposed to the ones I have worked on in MS Word.
Following up to some extent on Friday's discussion regarding the
'validation' of R, could I ask the list group's opinion on possible
advantages of R over Splus from a pharma/devices perspective? I wish to
exclude the obvious price difference, which doesnât seem to carry as much
weight as I
[EMAIL PROTECTED] wrote:
Following up to some extent on Friday's discussion regarding the
'validation' of R, could I ask the list group's opinion on possible
advantages of R over Splus from a pharma/devices perspective? I wish to
exclude the obvious price difference, which doesn’t seem to
18 matches
Mail list logo
